Showing results (311-320 of 433) with videos related to
Sort By:
Pageof 44
Veterinary Pathology|July 1, 1991
A novel DNA virus associated with feather inclusions in psittacine beak and feather diseaseK S Latimer, P M Rakich, W L Steffens, et al.Brain Communications|May 25, 2022
Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adultsMaria-Eleni Dounavi, Audrey Low, Graciela Muniz-Terrera, et al.Archives of Microbiology|June 27, 2003
Bacterial degradation of arsenobetaine via dimethylarsinoylacetateRichard O Jenkins, Alisdair W Ritchie, John S Edmonds, et al.Developments in Biological Standardization|January 1, 1984
The preparation, characterization and application of monoclonal antibodies to human prostatic acid phosphatase (PAP)C M Sturgeon, L R Micklem, A J Hussey, et al.Neuromolecular Medicine|August 13, 2008
Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's diseaseRobyn Carson, David Craig, Dominic Hart, et al.Neuroscience and Biobehavioral Reviews|July 26, 2021
Resting-state brain connectivity in healthy young and middle-aged adults at risk of progressive Alzheimer's diseaseLudmila Kucikova, Jantje Goerdten, Maria-Eleni Dounavi, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2017
Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's diseaseJames D Stefaniak, Li Su, Elijah Mak, et al.International Journal of Geriatric Psychiatry|May 27, 2003
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophreniaC W Ritchie, E Chiu, S Harrigan, et al.Veterinary Pathology|December 3, 2014
Aleutian Disease: An Emerging Disease in Free-Ranging Striped Skunks (Mephitis mephitis) From CaliforniaE E B LaDouceur, M Anderson, B W Ritchie, et al.Alzheimer'S Research & Therapy|October 21, 2016
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extensionLaura M Gault, Robert A Lenz, Craig W Ritchie, et al.Pageof 44